NCT01074892View on ClinicalTrials.gov

A Study Comparing Mirena and Systemic Progestin for Endometrial Hyperplasia

PHASE4CompletedINTERVENTIONAL
Enrollment

170

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Endometrial Hyperplasia
Interventions
DRUG

Provera (medroxyprogesterone/progestin)

10 mg tablet, 1 tablet per day taken 10 days per month Duration is 6 months

DRUG

Provera (medroxyprogesterone)

10 mg per oral tablet. One tablet per day for 6 months

DEVICE

Mirena (levonorgestrel)

Inserted in the uterine cavity and kept in situ for 6 months

Trial Locations (1)

9038

University Hospital of North Norway, Tromsø

All Listed Sponsors
collaborator

Helse Nord

INDUSTRY

collaborator

Norwegian Cancer Society

OTHER

lead

University Hospital of North Norway

OTHER

NCT01074892 - A Study Comparing Mirena and Systemic Progestin for Endometrial Hyperplasia | Biotech Hunter | Biotech Hunter